Back to Results
Vaibhav Kumar, MD, MRCP
Department + Services
Institute for Clinical Research and Health Policy Studies (ICRHPS), Predictive Analytics and Comparative Effectiveness (PACE) Center
|Programs + Specialties
||Cancer screening, cost effective analysis, predictive modelling
|Training + Education
Imperial College School of Medicine, London; Tufts Medical Center
2016, Senior Resident of the Year,Tufts Medical Center
2016, Emergency Medicine Resident of the Year, Tufts Medical Center
2013, Grand Round Presentation Winner, Manchester Royal Infirmary, UK
2009, Faculty of Medicine Award, Overall Performance in Medical Finals, Imperial, UK
2008, Sturges Prize, Microbiology, Imperial, UK
1. Hypoxia decreases HDAC2 in U937 cells as a possible mechanism of glucocorticoid resistance in COPD
British Thoracic Society Winter Meeting, London, UK 2007.
2. Individualized risk targeted approach to lung cancer screening: a cost-effectiveness analysis. Accepted to International Health and Economics Society, Boston, 2017.
1. Enhanced therapeutic benefits of Tumor Treating Fields (TTF) on superficially located Glioblastoma Multiforme (GBM)
Society of Neuro-Oncology Annual Scientific Meeting, Scottsdale, AZ, 2016.
2. Compliance and duration of treatment with Tumor Treating Fields (TTF) in adjuvant treatment for newly diagnosed Glioblastoma Multiforme (GBM) improves progression free survival (PFS) and overall survival (OS).
3. Society of Neuro-Oncology Annual Scientific Meeting, Scottsdale, AZ, 2016.
4. Progressive Multifocal Leucoencephalopathy a stroke mimic in the immunocompromised. Society of Acute Medicine, Manchester, UK 2012.
5. UK National Survey on role of transbronchial lung biopsy and bronchoalveolar lavage in the management of diffuse parenchymal lung disease. British Thoracic Society Winter Meeting, London, UK 2005.
6. A prospective study of yield of fibreoptic bronchoscopy (FOB) and CT thorax for lung cancer in patients with haempotysis with normal or non-localising CXR. British Thoracic Society Winter Meeting, London, UK 2003.
Vaibhav Kumar, MD, MRCP is originally from the United Kingdom and completed his medical school training at Imperial College London. After gaining membership to the Royal College of Physicians, Dr. Kumar moved to Boston to complete his residency at Tufts Medical Center. As an aspirational academic oncologist, he is a strong advocate for evidence-based cancer screening. Dr. Kumar's current interests lie in improving the efficiency and cost-effectiveness in the lung cancer screening process.
In his spare time, Dr. Kumar enjoys running and participates annually in either the BAA 10K or Half Marathon. He also enjoys playing golf, badminton and tennis.